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ABSTRACT  9 
Compartmentalization at the nanoscale is fundamental in nature, where the spatial segregation of 10 
biochemical reactions within cells ensures optimal conditions for regulating metabolic pathways. 11 
Here, we present a nature inspired approach to engineer enzymatic cascade reactions taking place 12 
between separate vesicular nanocompartments (polymersomes), each containing one enzyme 13 
type. We propose by the selected combination of enzymes, an efficient solution to detoxify the 14 
harmful effect of uric acid and prevent the accumulation of the derived H2O2, both being 15 
associated with various pathological conditions (e.g. gout and oxidative stress). Fungal uricase 16 
and horseradish peroxidase combined to act in tandem, were separately encapsulated within 17 
nanocompartments, equipped with channel porins as gates to allow passage of substrates and 18 
products from each step of the reaction. We established the molecular factors affecting the 19 
efficiency of the overall reaction, and the protective role of the compartments. Interestingly, the 20 
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cascade reaction between separate nanocompartments was as efficient as for free enzymes in 21 
complex media, such as human serum. The nanocompartments were non-toxic towards cells and 22 
more importantly, addition of the tandem catalytic nanocompartments to cells exposed to uric 23 
acid provided simultaneous detoxification of uric acid and the H2O2. Such catalytic 24 
nanocompartments can be used as a platform for understanding fundamental factors affecting 25 
intra-cellular communication and introduce non-native metabolic reactions into living systems 26 
for therapeutic applications. 27 
 28 
Introduction 29 
In nature, various enzymatic reactions occur in confined environments where substrates are 30 
channeled in between enzymes, or signaling molecules are released and travel between 31 
compartments1 serving to isolate reactive intermediates, concentrate substrates in a specific 32 
region or fine tune reaction pathways.2 Inspired by nature, significant efforts have been made to 33 
confine enzymes within nanocompartments, such as protein cages, lipid/polymer based 34 
compartments and layer by layer capsules, resulting in enzymatic compartments.1, 3-4 Enzymatic 35 
compartments are of particular interest as they offer a protective environment that increases the 36 
life-time of the encapsulated enzymes, essential for applications.5-6 In this respect, a particularly 37 
appealing class of compartments are polymersomes generated by self-assembly of amphiphilic 38 
copolymers, as their membrane is more stable than the lipid membrane of liposomes, while 39 
maintaining biocompatibility if the chemical nature of the copolymer is appropriately selected.7 40 
A key aspect to allow the enzymatic reaction to take place in situ, inside the cavity of 41 
polymersomes, is to render their membrane permeable thus enabling an exchange of substrates 42 
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and products with their surroundings. Various approaches have been reported: i) using inherently 43 
porous polymersomes,8-9 ii) using an external stimulus, such as pH, or by addition of a chemical 44 
agent to render the membrane permeable,10-11 and iii) inserting biopores or membrane proteins in 45 
the membrane.12-13 46 
Cascade reactions reported within nanocompartments mainly involve encapsulation of one type 47 
of enzyme and providing the second enzyme free in the surrounding medium.6, 14 However, if 48 
one partner of the cascade reaction is free in solution it might be degraded, resulting in a 49 
decrease or even termination of the overall reaction. Co-encapsulating enzymes within the same 50 
nanocompartment solves this issue, but only a low co-encapsulation efficiency can be obtained 51 
due to the statistic process of formation of multi-enzyme-loaded polymersomes.7  52 
A higher encapsulation efficiency of different enzymes can be achieved by linking the two 53 
enzymes together prior to encapsulation, using micrometer-sized compartments or the formation 54 
of compartments within compartments where small compartments and free enzymes are 55 
encapsulated inside micrometer-size compartments.9, 15-18 Both binding the enzymes in one 56 
complex and the approach of compartments within compartments, which uses organic solvents 57 
and emulsions, have the disadvantage of hindering the catalytic activity of the enzymes thus 58 
decreasing the efficiency or blocking the reaction.  59 
One approach, which allows for modularity while preserving the enzymes involved in the 60 
cascade reaction, is to design catalytic compartments working in tandem.7 However, there are 61 
only very few examples of catalytic nanocompartments (CNCs) working in tandem8, 10, 19-20 and, 62 
to the best of our knowledge, very few polymeric nanocompartments were evaluated in a more 63 
complex medium or in vitro.21 In addition, the kinetics of the cascade reactions in separate 64 
compartments and the molecular factors affecting them were not investigated to determine 65 
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whether such CNCs still function in a more complex medium than buffers or to propose a 66 
therapeutically relevant solution.  67 
Here, we present a bio-inspired approach to engineer CNCs working in tandem and propose, by 68 
an appropriate selection of the enzymes, an efficient solution to detoxify the harmful effect of 69 
uric acid and H2O2, associated with various pathologic conditions (e.g. gout and oxidative 70 
stress). Both gout and oxidative stress are known to induce severe health problems, associated 71 
with an increase in medical costs estimated to be above $6 billion per year in the US.22 We used 72 
an amphiphilic block copolymer poly(2-methyloxazoline)-block-poly(dimethylsiloxane)-block-73 
poly(2-methyloxazoline) (PMOXA6-PDMS44-PMOXA6) for the formation of the 74 
nanocompartments,23 and their membrane was rendered permeable by insertion of the bacterial 75 
porin Outer membrane protein F (OmpF).24 The role of the polymersomes is to protect the 76 
encapsulated enzymes in order to prolong their stability, as a crucial step towards translational 77 
applications, as is intended by our selected enzymatic reaction. We selected as enzymes for the 78 
cascade reaction uricase (UOX) and horseradish peroxidase (HRP), which uses H2O2 produced 79 
by UOX, as the substrate to initiate the second reaction (Scheme 1).25-27 This non-native 80 
combination of enzymes serves to sequentially decrease the concentration of uric acid and 81 
prevent the accumulation of H2O2, derived from the reaction of uric acid degradation, thus 82 
resulting in a dual therapeutic approach. While previous reports on cascade reactions between 83 
nanocompartments focused on the feasibility of model reactions,20 here we go one step further to 84 
understand the molecular factors associated with the cascade reaction between separate 85 
compartments and to optimize their overall function. Next, we investigate their ability to 86 
function at increasing distances to mimic intra- and intercellular bio-distances as well as in 87 
human serum, prior to applying them to decrease uric acid and the accumulation of H2O2, from 88 
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the cellular milieu to advance their therapeutic application. Our approach opens the avenue to 89 
combine different enzymes inside separate nanocompartments to obtain complex, novel-to-90 
nature enzymatic pathways with high potential in diagnostics and therapeutics. 91 
 92 
Scheme 1. Schematic representation of catalytic nanocompartments (OmpF: green rectangle) working in tandem and detailed 93 
cascade reaction mediated by a combination of uricase (UOX, red triangles) and horseradish peroxidase (HRP, blue hexagons). 94 
The oxidation of uric acid results in formation of 5-hydroxyisourate and hydrogen peroxide. The latter is a co-substrate for HRP 95 
in presence of substrate Amplex Ultra Red, AR. The final product, resorufin, can be monitored by fluorescence spectroscopy. 96 
 97 
Materials 98 
Dulbecco’s Modified Eagle Medium with 4.5 g L-1 D-Glucose (DMEM-GlutaMax) was 99 
purchased from Gibco life technologies. Fetal calf serum (FCS) was purchased from 100 
BioConcept. CellTiter 96® Aqueous One Solution Cell Proliferation Assay (MTS) was 101 
purchased from Promega. The triblock copolymer PMOXA6-PDMS44-PMOXA6 was kindly 102 
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provided by Prof. W. Meier, the University of Basel.23 All other reagents and enzymes were 103 
purchased from Sigma-Aldrich unless otherwise specified. 104 
Methods 105 
OmpF expression and extraction 106 
Wild-type OmpF was obtained according to a previously reported protocol,28 with a few 107 
modifications: bacteria was grown at 30 °C for 6 hours on Terrific Broth (TB) (Difco, USA) and 108 
all ultracentrifugations were performed at room temperature (RT).  109 
Preparation of catalytic nanocompartments 110 
All CNCs were prepared at RT using the triblock copolymer PMOXA6-PDMS44-PMOXA6 111 
(obtained according to a previously reported procedure23) and wild-type OmpF, via the film 112 
rehydration technique. Films were rehydrated to a final polymer concentration of 4 mg mL-1 with 113 
0.25 mg of UOX or HRP in PBS (pH 7) and 50 µl of previously dialyzed OmpF (60 µg mL-1 114 
final concentration) or an equivalent volume of dialyzed octyl glucopyranoside, OG (Anatrace, 115 
USA) 3% for the non-permeabilized CNCs. Samples were extruded through an Avanti mini-116 
extruder (Avanti Polar Lipids, USA) with a 200 nm pore diameter polycarbonate membrane (11 117 
times). Non-encapsulated enzyme was removed through size exclusion chromatography (SEC) 118 
(Sepharose 4B column; 30 cm length). 119 
 120 
Catalytic nanocompartment characterization — Static and Dynamic light scattering  121 
Light scattering (LS) experiments were performed at 25 °C, using an ALV/CGS–8F goniometer 122 
(Langen/Hessen, Germany) equipped with a frequency-doubled He-Ne laser (LS instruments, λ 123 
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= 633). Static light scattering (SLS) was performed in 5° steps between 50° and 135° and 124 
analyzed with Zimm plot software (LS Instruments). Dynamic light scattering (DLS) was 125 
performed at 90° and analyzed through nonlinear decay-time analysis supported by cumulant fit. 126 
 127 
Catalytic nanocompartment characterization — Transmission electron microscopy (TEM) 128 
CNC suspensions in PBS at 0.25 mg mL-1 were deposited on glow-discharged carbon grids 129 
(Quantifoil, Germany) stained with 1.5% uranyl acetate solution and deposited on carbon-coated 130 
copper grids. A transmission electron microscope (Philips Morgagni 268D) at 293 K was used.  131 
 132 
Catalytic nanocompartment characterization — Fluorescence correlation spectroscopy 133 
Vesicles were labeled with BODIPY 630/650 SE (Thermo Fisher Scientific, USA) 100 nM. 134 
All measurements were carried out using an LSM 880 confocal laser microscope (Carl Zeiss, 135 
Germany) with a 40x, 1.2 water immersion C-Apochromat objective lens. Measurements were 136 
performed at RT using a sample volume of 20 µL on a 22x50 mm glass slide. A HeNe laser at 137 
633 nm was used for excitation of the BODIPY fluorophore, at 1% attenuation and pinhole 62 138 
µm. The fluorescence signal was measured in real time and the autocorrelation function was 139 
calculated by the software calculator QuickFit 3.0.29 Measurements were recorded over 5 s and 140 
each measurement was repeated 30 times. Experimental auto correlation curves were fitted using 141 
a two-component model including triplet state:  142 
 = 1 + 1 + 	1 − 	 
 1
 1 + 1 +  
+ 1 + 1 +  
 
f1 and f2 are respectively the fraction of the particles of the corresponding component 1 (dye) or 2 143 
(vesicles), τD1 represents the diffusion time of the dye and τD2 the diffusion time of the vesicles, T 144 
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the fraction of fluorophores in triplet state with triplet time τtrip, N is the number of particles and 145 
R the structural parameter, fixed at 5, according to the guidelines from Zeiss. The τtrip and τD of 146 
free dye were determined independently, and subsequently fixed in the fitting procedure for dye-147 
interacting vesicles. The confocal volume of 1 fL, was obtained by a calibration with free 148 
BODIPY and was necessary to determine the concentration of fluorescent particles (knowing the 149 
number of particles detected in the volume).  150 
 151 
Enzyme quantification 152 
The non-encapsulated enzyme fraction was recovered via SEC and the enhanced Pierce™ 153 
Bicinchonic Acid (BCA) assay was performed according to the supplier’s protocol (Thermo 154 
Fisher Scientific, USA); instead of the BSA standards, both UOX (35 U mg-1) and HRP (300 U 155 
mg-1) calibration curves were prepared for the quantification of the respective samples. The 156 
amount of un-encapsulated protein was multiplied by the volume recovered from the column and 157 
then subtracted from the amount initially added to the rehydration solution, yielding the total 158 
amount of enzymes within the vesicles, divided by the volume of the vesicle (first fraction), i.e. 159 
the final concentration of the protein. This was performed on samples with no inserted OmpF, 160 
because the presence of the hydrophobic porin is not expected to influence the encapsulation 161 
efficiency of hydrophilic enzymes. The number of enzyme molecules was then divided by the 162 
number of vesicles, obtaining the number of enzymes per vesicle. 163 
 164 
Enzyme activity and kinetics 165 
Kinetic parameters were calculated using the Michaelis-Menten model:  166 
 =  !"#$%&'( + #$%& 
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)*!+ =  !"#,%&  
Where v is the velocity of the enzyme, Vmax is the maximum velocity at saturating concentration, 167 
[S]0 is initial the concentration of the substrate S, KM is the Michaelis-Menten constant. kcat is the 168 
turnover number, the number of chemical conversions per second, [E]0 is the concentration of 169 
catalytic sites (both for UOX and HRP it is equivalent with the concentration of enzyme). 170 
In all experiments involving a cascade reaction, UOX was added in excess to HRP, to partially 171 
compensate for the former enzyme’s lower activity, so that the ratio between production (from 172 
UOX, 35 U mg-1) and consumption (from HRP, 350 U mg-1) of hydrogen peroxide would not be 173 
the limiting factor. All enzymatic measurements were performed using a Spectramax M5 174 
microplate reader (Molecular Devices, USA), in a in a 96-well, flat bottomed UV-transparent 175 
plate (Corning, USA) for uric acid absorbance (290 nm) or in a black plate (Thermo Fisher 176 
Scientific) for resorufin fluorescence (excitation 570 nm / emission 595 nm). The final volume in 177 
each well was of 200 µL in PBS. UOX concentration was increased ten-fold in cascade reaction 178 
experiments, to counter the slower native activity per weight of the enzyme, compared to the 179 
downstream enzyme HRP. Both uric acid consumption and resorufin production were quantified 180 
by means of calibration curves (R2 > 0.9 for both curves). Each experiment was performed in 181 
triplicate and data was collected over 15 minutes (10 for the measurement of kinetic parameters). 182 
 183 
UOX kinetics 184 
UOX or UOX-loaded CNCs (final concentration of 3 µg mL-1) were incubated in presence of 185 
increasing concentrations of the substrate uric acid (25, 100, 200, 400 and 800 µM) and the 186 
initial velocity of the enzymatic reaction was determined. The consumption of uric acid was 187 
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 10
monitored and the data fitted with Graphpad Prism 7 software, obtaining KM, Vmax and kcat 188 
values.  189 
 190 
HRP kinetics 191 
HRP or HRP-loaded CNCs (final concentration of 3 µg mL-1) were incubated in the presence of 192 
10 µM H2O2 and increasing concentrations of Amplex Ultra Red (AR) (Invitrogen) ranging from 193 
0.2 to 20 µM. The initial velocity of the enzymatic reaction was determined by monitoring the 194 
formation of resorufin. The data was fitted using Graphpad Prism 7 software, obtaining KM, Vmax 195 
and kcat values. 196 
 197 
UOX-HRP cascade kinetics 198 
Both reactions were examined when in a cascade: UOX or UOX-loaded CNCs (final 199 
concentration of 3 µg mL-1) were added to HRP or HRP-loaded CNCs (final concentration 300 200 
ng mL-1) and both uric acid and AR were alternatively varied according to the previously listed 201 
concentrations. 202 
 203 
Amplex Ultra Red conversion assay in a cascade 204 
The same cascade reaction was tested at different conditions: UOX or UOX-loaded CNCs (final 205 
concentration of 3 µg mL-1) were added to HRP or HRP-loaded CNCs (final concentration 300 206 
ng mL-1), uric acid to a final concentration of 10 µM and AR to a final concentration of 1 µM, 207 
unless in controls where either substrate was missing and was substituted by the same volume of 208 
PBS. The reaction profile in presence of catalase (1000 U mg-1, final concentration of 10 µg mL-209 
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1) was blanked against the reaction profile of catalase alone in presence of AR, as catalase too 210 
has a heme center capable of reacting with the fluorogenic molecule. 211 
 212 
Catalytic nanocompartment resilience to degrading agents 213 
Concentrations were 3 µg mL-1 for UOX or UOX-CNC and 300 ng mL-1 for HRP or HRP-CNC. 214 
For the heat resistance assay, aliquots of the polymersome were incubated at 37, 50, 60 and 75 215 
°C for either 10 or 30 minutes. For the chemical and enzymatic resistance assays, aliquots were 216 
incubated with 6 M guanidine hydrochloride (GdnHCl) for 1 hour and 0.1 mg ml-1 Proteinase K 217 
for 2 hours (37 °C), respectively. Proteinase K was added in excess with respect to the other 218 
enzymes (free and encapsulated). The production of resorufin was compared to that of the 219 
cascade reaction with no additional elements and the ratio was calculated. To verify unspecific 220 
binding, the same amount of enzyme (either UOX or HRP) was added to pre-formed empty 221 
vesicles and then purified with the same protocol, then mixed with vesicles encapsulating the 222 
other enzyme and the cascade kinetics were followed. 223 
 224 
Activity of CNCs in serum 225 
Activity in biological fluid was tested in human blood serum in which uric acid was dissolved to 226 
a final concentration of 500 µM at 37 °C, mimicking hyperuricemia. UOX or UOX-CNCs were 227 
added to reach a final concentration of 18 µg ml-1, HRP or HRP-CNCs to 900 ng ml-1, AR to 10 228 
µM. The decrease of absorbance at 290 nm was monitored over the course of 6 hours. The 229 
degradation of uric acid was defined as	 230 
./01	23/0	453/4/0167 = 	 ∆9:;<=>?@	ABCDEAEB∆9:;<=>BF	ABCDEAEB , 231 
 232 
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Dependence of distance over reaction efficiency 233 
Knowing the amount of CNCs in a given volume (obtained from FCS measurements), it was 234 
possible to calculate the mean inter-vesicle distance, assuming a cubic space occupied by the 235 
compartments, as  236 
1
G
 
where N is the number of particles (sum of UOX and HRP loaded-polymersomes) and V is the 237 
reaction volume. A constant concentration of UOX-CNCs was mixed with a solution of HRP-238 
CNCs at concentrations: 2x, 1x, 0.5x, 0.25x, 0.1x, 0.02x, 0.01x and 0.005x. The decrease in 239 
concentration of HRP-CNCs induced an increase of the mean distance between polymersomes, 240 
which was calculated using N = NUOX-CNC + NHRP-CNC. Resorufin production was monitored as 241 
described above. 242 
 243 
Cell culture  244 
HEK293T cells were cultured in a humidified atmosphere with 5% CO2 at 37 
oC in Dulbecco’s 245 
Modified Eagle Medium with GlutaMAXTM-I (4.5 g L-1 D-Glucose, Gibco life technologies) and 246 
supplemented with 10% Fetal calf serum (FCS, BioConcept), 100 U mL-1 penicillin and 100 µg 247 
mL-1 streptomycin (Sigma Aldrich). 248 
 249 
Cell viability assay-MTS 250 
For cell viability assessment, a CellTiter 96® Aqueous One Solution Cell Proliferation Assay 251 
(MTS, Promega) was used according to manufacturer instructions. Cells were seeded (5 000 252 
cells/well in 100 µL cell culture medium) in a 96-well plate and incubated for 24 h. After 24 h 253 
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the UOX-HRP-CNCs (concentrations ranging from 1.18 to 18 µg mL-1 of total polymer) were 254 
diluted in PBS and added to the cells to reach a final volume of 200 µ/well. After 24 h incubation 255 
in presence of the CNCs, 20 µL MTS reagent was added to each well. After 4 h absorbance was 256 
measured at 490 nm using a Spectramax M5e plate reader. Background absorbance from control 257 
wells containing all assay components without cells was subtracted from each well and data 258 
normalized to control cells containing all components except CNCs.  259 
 260 
Cell viability in presence of uric acid  261 
Cells were seeded at a density of 5 000 cells/well in 100 µL cell culture medium, in a 96-well 262 
plate and incubated for 24 h. Next, cells were dosed with 250 or 500 µM of uric acid, final 263 
concentration, in the presence or absence of UOX-HRP-CNCs (18 µg mL-1 for UOX and 0.9 µg 264 
mL-1 for HRP, final concentrations in 200 µL final volume) or in the presence of free enzymes 265 
(UOX and HRP) at the same concentration. AR (1 µM, final concentration in 200 µL final 266 
volume) was added to each well as a co-substrate for the HRP-CNCs. After a 24 h incubation 267 
period, 20 µL MTS reagent was added to each well. The absorbance was measured at 490 nm 268 
after 4 h. Background absorbance from control wells containing all assay components apart from 269 
the cells was subtracted from each well and data normalized to control cells containing all 270 
components except CNCs and uric acid.  271 
 272 
Statistics 273 
Multiple t-tests were performed using Graphpad Prism 7 software, comparing datasets, without 274 
assuming constant standard deviation (SD). Statistical significance (p<0.05) was corrected using 275 
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the Holm-Sidak method. Significance was marked as * p < 0.05, ** p < 0.01, *** p < 0.001, 276 
sample size was always n = 3. 277 
 278 
Results and Discussion 279 
Formation of UOX-Catalytic nanocompartments and HRP-Catalytic nanocompartments 280 
We encapsulated UOX and HRP inside the supramolecular assemblies formed during the self-281 
assembly process of the copolymer by using film rehydration method due to its mild conditions, 282 
which do not affect the biomolecules.7, 30 The architecture of the supramolecular assemblies in 283 
presence and absence of enzymes was established by a combination of LS and TEM. We used 284 
SLS to obtain the radius of gyration Rg, and DLS for the hydrodynamic radius Rh. The ratio of 285 
these values Rg/Rh, called ρ-factor, is indicative of the different architectures, e.g. 1 for hollow 286 
spheres while 0.77 for solid spheres.31 In the case of empty supramolecular assemblies, Rg and 287 
Rh values were 70 ± 33 nm and 84 ± 25 nm respectively, and the calculated ρ-factor of 0.96 288 
indicates hollow sphere architecture, thus formation of polymersomes. In the presence of UOX 289 
(UOX-CNC), we determined for the supramolecular assemblies an Rg of 68 ± 12 nm and Rh of 290 
73 ± 33 nm (ρ = 0.95), while in the presence of HRP (HRP-CNC) they had an Rg of 74 ± 35 nm 291 
and Rh 85 ± 41 nm (ρ = 0.87) (Figure S1). In both cases, the enzymes did not affect the self-292 
assembly process and resulted in polymersome architecture, which agrees with the TEM 293 
micrographs (Figure 1A and 1C, Figure S2 and S3).  294 
In order to quantify the amount of encapsulated enzymes inside the nanocompartments, we used 295 
a combination of brightness measurements in FCS and BCA. FCS measures the fluorescence 296 
fluctuations due to the Brownian motion of fluorescent species in a fL-sized volume, yielding 297 
molecular parameters such as diffusion time and the number of particles that can be used to 298 
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evaluate interactions/encapsulation of the fluorescent dyes with/in supramolecular assemblies.32 299 
By labeling the vesicle membrane with BODIPY 630/650, and using a 2-component fit (fixing 300 
the diffusion time of free dye as one of the components) we obtained their average diffusion time 301 
(τD 5000 µs for both CNCs, as compared to τD = 57 µs of the free dye) and overall number of 302 
fluorescent vesicles in solution. The fraction of dye-polymersomes was 99% for UOX-CNCs and 303 
94% for HRP-CNCs (2.6×1011 and 3.9×1011 polymersomes µL-1, respectively), while that of the 304 
free dye 1% and 4% thus indicating that most of the dye partitioned into the polymersome 305 
membrane (Figure 1B and 1D).  306 
A total protein concentration of 30 µg mL-1 for UOX and 18.6 µg mL-1 for HRP, was obtained 307 
by BCA assay (Figure S4). Dividing the protein concentration by the number of polymersomes 308 
obtained by brightness measurements, we determined an average of 11 ± 7 enzymes in UOX-309 
CNCs and 6 ± 2 enzymes in HRP-CNCs. An encapsulation efficiency of 36 ± 12 % for UOX and 310 
22 ± 4% for HRP inside CNCs was obtained, in agreement with the encapsulation efficiency 311 
values obtained for other enzymes inside polymersomes.7, 30 A number of 11 312 
OmpF/polymersome was inserted as we used similar conditions as previously reported.33 We 313 
kept the amount of porin constant in order to distinguish the effect of all other molecular factors 314 
on the cascade reaction. 315 
 316 
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 317 
Figure 1. Formation of UOX-CNCs and HRP-CNCs. A: TEM micrograph of UOX-CNCs (scale bar: 200 nm). B: normalized 318 
FCS autocorrelation curve of the dye labeled UOX-CNCs (dots: normalized raw data; solid line: fitted data, black line: free 319 
BODIPY 630/650). C: TEM micrograph of HRP-CNCs (scale bar: 200 nm). D: normalized FCS autocorrelation curve of the 320 
dye-labeled HRP-CNCs (dots: normalized raw data; solid line: fitted data, black line: free BODIPY). 321 
 322 
Overall enzymatic efficiency of CNCs  323 
Having determined the amounts of encapsulated enzymes, we used the same concentrations in 324 
bulk to evaluate the efficiency of the cascade reaction. The cascade reaction takes place when the 325 
enzymes are free or encapsulated in separate nanocompartments equipped with OmpF (Figure 326 
2A). The reaction cannot proceed when the membrane of the nanocompartments is not equipped 327 
with OmpF, to allow molecular passage through (Figure 2B), or when one of the enzymes or 328 
substrates is removed from the cascade (Figure 2C).  329 
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 330 
Figure 2. Cascade reaction with different setups. A: Enzyme kinetics when both enzymes are free (red), only HRP is free (light 331 
green), only UOX is free (dark green) and both UOX and HRP are encapsulated inside polymersomes (blue). B: Cascade with 332 
permeabilized CNCs (blue), unpermeabilized UOX-loaded polymersomes (olive), unpermeabilized HRP-loaded polymersomes 333 
(black). C: Cascade reaction with both CNCs and the corresponding substrates (blue), and in the absence of one of the reaction 334 
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compounds: HRP (orange), UOX (brown), AR (grey), and uric acid (purple). Error bars are given as mean ± SD (n = 3), in some 335 
cases bars are smaller than the corresponding dot. 336 
 337 
As expected, the cascade reaction between separate nanocompartments is significantly slower 338 
than that of the free enzymes. Going a step further, we were interested in establishing the effect 339 
of the molecular diffusion through OmpF of substrates and products, examining the probability 340 
that the product of the first reaction penetrates in a second CNC containing the HRP and 341 
studying the effect of the distance between different CNCs on each step of the reaction and on its 342 
overall efficiency. The conversion of AR to resorufin (AR conversion) was used as a comparison 343 
standard, because it represents the last step of the cascade reaction and therefore accounts for 344 
whether the whole cascade reaction takes place. First, we studied the influence of molecular 345 
diffusion through OmpF as a key factor, which might limit the in situ enzymatic reaction inside 346 
CNCs. Having one of the enzymes free in solution and the second one encapsulated in the CNCs, 347 
AR conversion decreased compared with that of free enzymes. When HRP was surrounding 348 
UOX-CNCs, a slight decrease in AR conversion to 92% was observed, while when UOX was 349 
free around the HRP-CNCs, a significant decrease in AR conversion to 13% was obtained 350 
(Figure 3). When both enzymes were encapsulated within the CNCs working in tandem, AR 351 
conversion decreased significantly to 3% after 15 minutes. As H2O2 is known to rapidly diffuse 352 
through OmpF and it passes through the same barriers (membrane and inter-vesicle space) 353 
regardless of which enzyme is inside the CNCs, its effect is only minor and is due to its 354 
probability to interact with HRP. When only UOX is inside the CNCs, the slight decrease in AR 355 
conversion is due to an inhomogeneous distribution of UOX-CNCs, which are the only source of 356 
H2O2. When HRP is inside the CNCs, the greater decrease in AR conversion is related to the 357 
slow diffusion of AR through the OmpF pores, which is also the bottleneck for the cascade 358 
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reaction between CNCs in tandem. Another factor that contributes to the significant decrease in 359 
the reaction efficiency when CNCs are in tandem is the inhomogeneous CNC distribution which 360 
reduces the probability that the substrates of the second reaction reach the HRP-CNCs. Besides, 361 
the necessity of H2O2 transfer from UOX-CNCs to HRP-CNCs is proven by introducing free 362 
catalase to the reaction mixture, as a competing enzyme that converts H2O2 to water and oxygen 363 
(without Amplex Red as co-factor): when added, catalase strongly hinders the reaction mediated 364 
by HRP (Figure S5A).  365 
 366 
Figure 3. Conversion of AR to resorufin by a cascade enzymatic reaction when: both enzymes are encapsulated (blue), and only 367 
HRP is encapsulated (HRP-CNCs) and UOX is free (yellow), only UOX is encapsulated (UOX-CNCs) and HRP is free (green), 368 
both enzymes are free (red). Error bars are given as mean ± SD (n = 3). 369 
 370 
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Kinetic analysis of CNCs   371 
It is already known that encapsulation in polymersomes affects the kinetic parameters of 372 
enzymes, by increasing their affinity for the substrates or decreasing the velocity, because they 373 
are in a different environment than in solution.30 To characterize the behavior of CNCs, we first 374 
compared the kinetic parameters of CNCs when isolated and then when acting in tandem by 375 
using the Michaelis-Menten model (Table 1 and 2, Figure S6). Both steps of the cascade reaction 376 
can be modeled in a first approximation by using Michaelis-Menten kinetics because in the first 377 
reaction (UOX-CNCs) uric acid is added in excess, and for the second step both substrates are in 378 
excess in the surroundings of the HRP-CNCs (AR added in excess in the medium, and H2O2 379 
generated by UOX-CNCs with Vmax of 1.47x10
-3 
µM/min, which is one order of magnitude 380 
higher than Vmax of HRP, as presented in Table 1 and 2). 381 
KM, the Michaelis-Menten constant, defines the affinity of the enzyme for the substrate, and the 382 
apparent Vmax represents the maximal velocity at which the enzyme operates once it is saturated 383 
by the substrate. As both KM and Vmax are intrinsic characteristics of the enzymes in specific 384 
conditions, it is expected that these parameters are not affected by the enzyme encapsulation (if 385 
the substrate/products diffusion is not changing due to possible barriers). However, we observe a 386 
completely different situation: both KM and Vmax are affected by enzyme encapsulation (Table 1 387 
and 2). 388 
The apparent KM of both enzymes is lowered once confined in the nanocompartment, 4-times for 389 
UOX-CNC and 1.5 times for HRP-CNC, which is in agreement with a previous publication 390 
where encapsulated enzymes tend to exhibit a lowering in KM.
34 However, this is not surprising 391 
as the hollow cavity of a polymersome offers a more confined space, increasing the probability 392 
of the substrate to access the catalytic center of the enzyme.30 In addition, there is a decrease in 393 
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Vmax and kcat values. The decrease of both Vmax and kcat is significant in the case when UOX is 394 
encapsulated in the CNCs (both for free HRP and for HRP-CNCs) (Table 1). On the contrary, 395 
when HRP is encapsulated (free UOX and UOX-CNCs), the decrease in Vmax and kcat values is 396 
noticeably smaller (Table 2). We assume the change in kcat values is associated with a slower 397 
influx of the substrates to the enzyme’s active site, a slower efflux of the products or a 398 
combination thereof when the enzymes are inside the CNCs due to various barriers associated 399 
with the polymersomes architecture. Similarly, kcat /KM values decrease when the enzymes are 400 
inside the CNCs. While the substrate can easily encounter the enzyme once inside the 401 
compartment, the permeation through the membrane that is mediated by OmpF pores effectively 402 
hinders the total activity of the cascade. The effect of diffusion to the enzyme is a well-known 403 
parameter affecting and altering enzyme kinetics, as it can become the actual limiting factor in 404 
their efficiency.35-36 405 
Table 1. Apparent kinetic parameters for UOX: Michaelis-Menten constant (KM), maximal enzyme velocity (Vmax ), turnover 
rate (kcat) and catalytic efficiency (kcat/ KM ). 
 
Free UOX 
Free UOX in 
cascade 
UOX-CNC 
UOX-CNC in 
cascade 
KM (µM) 3.70×10
2 3.68×102 8.32×101 9.09×101 
Vmax (µM/min) 2.47×10
-1 2.77×10-1 1.22×10-4 1.47×10-3 
kcat   (1/s) 2.72 2.55 1.34×10
-3 2.00×10-3 
kcat  /KM (1/(µM s)) 7.30×10
-3 7.52×10
-3 1.60×10-5 2.20×10-5 
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 406 
 407 
We exclude that the decrease in enzyme activity inside the CNCs is due to the confinement of 408 
enzymes: encapsulated UOX (molecular radius 4.27 nm37) and HRP (molecular radius 2.98 409 
nm38) move free in a 1000-fold and 12000-fold greater volume inside the polymersome than their 410 
intrinsic volume, respectively. We calculated the inner volume of polymersomes as the volume 411 
of a sphere with a radius R = Rh – d, where d is the polymersome membrane thickness of 10.7 412 
nm (previously determined for PMOXA6-PDMS44-PMOXA6 compartments
39). 413 
Role of compartmentalization on CNC activity 414 
In a similar manner as is the case for liposomes, the polymeric membrane of nanocompartments 415 
is expected to offer protection of the encapsulated payload from external agents that would 416 
degrade it, as for example proteolytic attack.40 We wanted to establish the protective role of the 417 
Table 2. Apparent kinetic parameters for UOX: Michaelis-Menten constant (KM), maximal enzyme velocity (Vmax ), 
turnover rate (kcat) and catalytic efficiency (kcat/ KM ). 
 
Free HRP 
Free HRP in 
cascade 
HRP-CNC 
HRP-CNC in 
cascade 
KM (µM) 3.50×10
 3.0×10 2.22×10 1.92×10 
Vmax (µM/min) 7.82×10
-4 8.19×10-4 4.21×10-5 1.32×10-4 
kcat   (1/s) 1.14×10
-2 1.12×10-2 1.94×10-3 6.19×10-3 
kcat  /KM (1/M/s) 4.10×10
-4 4×10-4 2.80×10-4 3.22×10-4 
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nanocompartments in the presence of physical factors such as high temperatures and different pH 418 
values as well as degrading agents (GdnHCl and Proteinase K). We quantified the “activity 419 
retention” as the ratio between the production of resorufin under standard conditions (RT, pH 7) 420 
and in the presence of degrading conditions. Wild-type OmpF is known to be stable at relatively 421 
extreme pH,41-43 resistant to proteolysis,44 chaotropic agents and temperatures up to 75 °C.43 422 
Therefore, the porin is neither affected by the mild conditions of the rehydration method used to 423 
generate the catalytic compartments, nor by the presence of a more complex environment or 424 
degrading agents, because it is also protected inside the compartments membrane.  425 
While below 37°C both encapsulated and free enzymes preserve their activity, for higher 426 
temperatures, a decrease in activity is observed, but to a significantly higher degree for the free 427 
enzymes (Figure 4A, Figure S5D and S7). The ability of the polymeric membrane to protect the 428 
encapsulated payload from the effect of higher temperatures,45-46 which denatures the enzymes, 429 
is essential for translational applications. The effect of pH was less straight forward, as these two 430 
enzymes have a different pH optima: basic for UOX and acidic for HRP.47-48 While at pH 3 there 431 
is no apparent gain in activity from the enzyme encapsulation, at pH 9 the CNCs are significantly 432 
more active than the free enzymes acting in tandem (Figure 4B). The enzyme activity is further 433 
affected upon encapsulation due to a complex scenario: i) the interplay between the lower 434 
stability of HRP at higher pH values49 and the basic pH optimum of UOX, ii) the stabilization of 435 
HRP –known to interact with hydrophobic substrates50– once inside the compartment, and iii) an 436 
increase in enzyme accessibility for the substrates due to the confined reaction space.30 Therefore 437 
the effect of the pH on activity is less evident when the enzymes are free in solution and no 438 
confinement effects are present. However, we chose a neutral pH to evaluate the CNCs in 439 
tandem to be closer to physiological conditions, at which both enzymes are still active (Figure 440 
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S5B), and where both the free enzymes and encapsulated ones have similar activity retention 441 
values. 442 
The addition of an enzyme denaturing chemical agent, such as GdnHCl, decreased the enzyme 443 
activity, which is significantly more pronounced when the enzymes are free. This clearly 444 
indicates the protective role of compartmentalization (Figure 4C). The decrease in activity 445 
retention values in the case of CNCs in tandem is mainly due to the diffusion of GdnHCl (95 Da) 446 
through OmpF, which has a weight cut-off of 650 Da.51 Even though in a previous report 447 
GdnHCl diffused through the polymersome membrane,52 this is not observed here as shown by 448 
the highly retained activity. The permeability of PMOXA-PDMS-PMOXA membranes varies 449 
depending on the molecular factors, such as the thickness of the membrane, the polydispersity of 450 
the copolymer chains or the conditions in which they are formed. In addition to the small number 451 
of inserted OmpF that are enough to allow in situ enzymatic reaction, the innate resistance 452 
towards denaturation of UOX 53-54 and the possible stabilization of HRP due to interactions with 453 
the membrane are responsible for maintaining enzymes’ activity in the case of our CNCs, even in 454 
presence of GdnHCl.  455 
To mimic a proteolytic attack, we added Proteinase K both to free enzymes and the CNCs for 2 456 
hours. While a significant decrease in activity retention was observed for the free enzymes (18 ± 457 
1%), in the case of CNCs the decrease was considerably smaller (83 ± 3%), additionally showing 458 
that a small fraction of enzyme molecules was adsorbed at the outer interface of the 459 
polymersome33 (Figure 4D). We considered the overall activity of the CNCs as a whole; 460 
however, by adding free enzymes to empty vesicles and then purifying them, it was possible to 461 
detect a certain amount of activity due to unspecific binding in the cascade for HRP, estimated to 462 
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be around 3% of the total (Figure S5C and Table S1). The auto-oxidation of AR was also taken 463 
into account, and subtracted in all blanks. 464 
 465 
Figure 4. Stability of catalytic nanocompartments and free enzymes (activity normalized against CNCs (blue) or enzymes (red) at 466 
RT, neutral pH, no agents). A: protection from heat. B: protection from extreme pH. C: protection from denaturing agent 467 
GdnHCl. D: protection from proteolysis. Error bars are given as mean ± SD (multiple t - test, * p < 0.05, ** p < 0.01, *** p < 468 
0.001, n = 3). 469 
 470 
The effect of distance on the efficiency of the CNCs in tandem 471 
The passage through barriers and diffusion between compartments represents an essential point 472 
in bio-communication because products have, in some cases, to travel to different cellular 473 
compartments or take part in inter-cellular communication. Most organelle-to-organelle 474 
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communications in the cell happen via close association below 50 nm55 and the average synaptic 475 
cleft is around 20 nm,56 whereas it is estimated that a single cell can effectively communicate 476 
between 5 and 10 µm in autocrine signaling and up to 250 µm in paracrine signaling.57-58 In such 477 
cases of communication between organelles or cells, there is no longer a homogeneous 478 
distribution of enzymes or receptors but local high concentrations and otherwise empty or low 479 
density interstices. We used our CNCs in tandem to mimic communication between bio-480 
assemblies and see the effect of distance on the overall cascade reaction efficiency. We assumed 481 
a cubic volume for the compartments, so that the mean inter-compartment distance is calculated, 482 
based on the polymersome density obtained by FCS.  483 
The AR conversion values in the case of CNCs in tandem remains almost constant (with some 484 
values higher than 100% as values fluctuate around the mean obtained at 0.8 µm, set as 485 
reference) until the mean distance between CNCs is 1.3 µm, then the values decrease 486 
significantly. This suggests that the diffusion of molecules through the OmpF pores represents 487 
the dominant factor for distances lower than approximately 1.30 µm. Interestingly, the ratio 488 
between the mean inter-compartment distance and their diameter is about 10, which has the same 489 
order of magnitude as the ratio between a mean cell-cell communication distance for cells with a 490 
1 µm diameter, such as bacteria.59 For distances between CNCs higher than 1.3 µm, the cascade 491 
reaction is rapidly hindered due to a decrease in the probability that H2O2 encounters a HRP-492 
CNC (Figure 5). These distances are consistent with distances typical for autocrine signaling. 493 
Therefore our findings, based on tandem CNCs in a simplified medium, represents a first 494 
necessary step for better understanding cell communication. 495 
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 496 
Figure 5. AR conversion by cascade reaction inside CNCs in tandem at different mean inter-vesicle distances. Error bars are 497 
given as mean ± SD (n = 3).  498 
CNCs in tandem in biologic conditions 499 
We then evaluated the functionality of the CNCs in biological conditions, both in biofluids and 500 
upon incubation with cells, as more apropriate to advance translational applications. First, we 501 
used human blood serum where uric acid was dissolved to reach levels similar to those 502 
considered typical for hyperucemia (>6.8 mg dL-1 in men60). A simple model, defined as 503 
∆9:;<=>?@	ABCDEAEB∆9:;<=>BF	ABCDEAEB
 for the dilutions of HRP-CNCs, gives the relative efficiency of the cascade 504 
reaction, which we called Relative Urate Degradation (R.U.D.) (Figure 6A). Interestingly, in 505 
such a complex medium, CNCs facilitate the clearance of uric acid at a comparable rate to the 506 
free enzyme. The addition of HRP removes H2O2, pulling the first reaction forward according to 507 
Le Chatelier’s principle. In addition, we observed no aggregation of polymersomes in serum, in 508 
agreement with reported results on similar polymers.61 Note that only in PBS the free enzymes 509 
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are better in terms of the cascade efficiency than when encapsulated inside polymersomes. 510 
However, in serum, they perform similarly, which emphasizes the role of the compartments in 511 
protecting the encapsulated enzymes in these conditions (37 °C, 6 hours), and support our 512 
approach for further cell assessment. Further studies, beyond the scope of the present one, are 513 
necessary to understand the bio-molecular factors affecting the efficiency of the overall cascade 514 
reaction between CNCs in human serum.  515 
Second, we determined the ability of the CNCs to metabolize uric acid and degrade H2O2 upon 516 
incubation with cells, as an essential step towards medical applications. First, we evaluated the 517 
cytotoxicity of CNCs when incubated with HEK293T cells overnight at different concentrations 518 
of the CNCs (measured in polymer concentration) by MTS assay. CNCs have no cytotoxic effect 519 
towards the cells, even at the highest polymer concentration (0.19 µg mL-1) (Figure 6B). Next, 520 
CNCs were incubated with HEK293T epithelial cells for 24 h in the presence of increasing 521 
amounts of uric acid (250 and 350 µM): at physiological concentration and at the lower end of 522 
hyperuricemia values. CNCs, known to be eventually internalized by cells,7 were added together 523 
with uric acid because it accumulates extracellularly to toxic levels: in this manner CNCs 524 
directly protect cells by degrading uric acid. Cell viability decreased to around 60% in the 525 
presence of 250 µM uric acid. By addition of either free enzymes or the CNCs, the cell viability 526 
was unaffected by the presence of uric acid. Increasing the amount of uric acid to 350 µM 527 
reduces the viability of the cells to 2%, while the cascade reaction of the free enzymes and of the 528 
CNCs in tandem induce a protective effect against uric acid. In addition, due to the combination 529 
of enzymes, H2O2 is also degraded as a result of the succesful cascade reaction process (Figure 530 
6C and D).  531 
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 532 
Figure 6. Activity of CNCs and free enzymes in blood serum and their interaction with cells. A: clearance of urate with both 533 
CNCs (solid blue), UOX-CNC only (striped blue, no HRP-CNC), both free enzymes (solid red) and UOX only (striped red, no 534 
HRP-CNC) B: cell viability of HEK293T cells incubated with CNCs at different concentrations (expressed as polymer 535 
concentration). C: scheme of the CNC-cell interaction and detoxifying activity of the UOX-HRP cascade on cells only (green), 536 
cells with free enzymes (blue) and cells with CNCs (red). Error bars are given as mean ± SD (multiple t - test, * p < 0.05, ** p < 537 
0.01, *** p < 0.001, n = 3). 538 
Conclusions 539 
We designed two spatially segregated catalytic nanocompartments to support a cascade reaction 540 
between them, mimicking sequential reactions between biosystems. By an elegant selection of 541 
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the enzyme combination, we applied these catalytic nanocompartments in tandem to decrease 542 
uric acid and H2O2, both involved in various pathologic conditions ranging from gout to 543 
oxidative stress. A thorough analysis of the factors affecting the overall efficiency of the cascade 544 
reaction between CNCs indicated the protective role of the compartments, which provide a shield 545 
for the encapsulated enzymes, especially important in biological fluids and cellular environment. 546 
For the first time, a kinetic evaluation of a cascade reaction between segregated reaction spaces 547 
at the nanoscale has been achieved. We elucidated the limiting factors for the overall reaction: i) 548 
the diffusion through the membrane pores inserted into the walls of the compartments and ii) the 549 
probability of the products from the first reaction to encounter CNCs containing the second 550 
enzyme and reach the encapsulated enzyme molecules. A balance is necessary between the 551 
protective role of the nanocompartments and the factors that decrease the efficiency of the 552 
cascade reaction for translational applications. This cascade reaction in separate compartments 553 
has been successfully performed in serum and then used to decrease both uric acid and the 554 
derived H2O2 from the cellular milieu as a first step towards medical applications. Our study is 555 
the first one that proves that a two-compartment cascade reaction acts in cellular conditions, thus 556 
contributing to the understanding of the design of complex catalytic compartments to cope with 557 
biological requirements.  558 
 559 
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